Speakers

Jeremy A. Abbate

VP and Publisher

Scientific American Inc.

Frida Abramov

Senior Director of Global Medical Affairs

Emerging Viruses/COVID-19, Gilead Sciences, Inc.

Eric Aguiar

Partner

Aisling Capital LLC

Ruxandra Draghia Akli

Global Head of Global Public Health R&D

Janssen Research & Development LLC

Philippe Alen

VP and Head of Business Development, Licensing and Alliance Management Cardiovascular Diseases

Bayer Pharmaceuticals

Rubal Bedi

Venture Partner and Head of Corporate Venture Group

HOYA

Jeffrey Bockman

Executive VP and Oncology Practice Head

Cello Health BioConsulting

Gabriel P. Cavazos

Managing Director, Investment Banking

SVB Leerink

Tak Cheung

Principal

New Enterprise Associates (NEA)

Grace Colon

CEO

InCarda Therapeutics Inc.

Alice Valder Curran

Partner

Hogan Lovells

Marianne De Backer

Head of Business Development & Licensing, Pharmaceutical Division

Bayer

Rahul Dhanda

Co-Founder and CEO

Sherlock Biosciences

Steve Dickman

CEO

CBT Advisors

Bill Evans

CEO and Managing Director

Rock Health

Sam Fazeli

Director of EMEA Research and Senior Pharmaceutical Analyst, BI

Bloomberg L.P.

Hill Ferguson

CEO

DoctorOnDemand

Phyllis Ferrell

Global Head of External Engagement, Alzheimer's Disease and Neurodegeneration

Lilly

Amy Finan

CEO

Sabin Vaccine Institute

Andrew Fish

CSO

AdvaMed

Stephen F. Flaim

Senior Special Advisor and Investor-in-Residence

NIH

Mani Foroohar

Managing Director and Senior Research Analyst

SVB Leerink

Maria Fotiu

Executive VP of Decentralized Solutions

Syneos Health

Kyle Gano

Chief Business Development and Strategy Officer

Neurocrine

Cathy Gao

VP

Sapphire Venture

Julie Gerberding

Executive VP and Chief Patient Officer

Merck & Co. Inc.

Jennifer Friel Goldstein

Managing Partner, Life Science and Healthcare

SVB Capital

Marc Goodman

Managing Director

SVB Leerink Equity Research, Neuroscience

Asthika Goonewardene

Managing Director and Senior Analyst

Truist Securities

Shaun Grady

Senior VP of Business Development Operations

AstraZeneca

Kimberly Ha

CEO and Founder

KKH Advisors

Leslie Haas

Manager of Digital Health Strategy

Stanford Health Care

Richard Hachett

CEO

CEPI

Katya Hancock

Investment Network Director

StartUp Health

Paul J. Hastings

President and CEO

Nkarta Therapeutics, Inc. (NASDAQ GS: NKTX)

Rachel Haurwitz

President and CEO

Caribou Biosciences, Inc.

Abraham Heifets

Co-Founder and CEO

Atomwise

Berthold Hinzen

VP and Head of BD&L Therapeutic Areas

Bayer AG

Beth Hoffman

Founder, President and CEO

Origami Therapeutics

Robert Jacks

President and CEO

Indalo Therapeutics

Rachelle Jacques

CEO

Enzyvant

Alyssa Jaffee

Partner

7wireVentures

Ben Johnson

Managing Director and Head of National Early Stage Life Science

Silicon Valley Bank

Michelle Keefe

President, Commercial Solutions

Syneos Health

Armen Kherlopian

Co-Founder

BAJ Accelerator

David J. Kim

Managing Director

DigiTx Partners

Nina Kjellson

General Partner

Canaan

Arthur Klausner

President and CEO

Goldilocks Therapeutics, Inc.

William Kolb

Partner

Foley Hoag

Peter Kolchinsky

Founder and Managing Partner

RA Capital Management

Michael G. Kurilla

Director of Division of Clinical Innovation

National Center for Advancing Translational Sciences, National Institutes of Health

Tomas Landh

Innovation Sourcing VP, Senior Principal Scientist

Novo Nordisk

Taja Lester

Managing Partner

Health Equity Capital

Jeremy Levin

Chairman and CEO

Ovid Therapeutics

Philippe Lopes-Fernandes

Executive VP and CBO

Ipsen

Gail Maderis

President and CEO

Antiva Biosciences

Sean Marett

CBO and CCO

BioNtech (NASDAQ: BNTX)

John McDonald

Corporate VP and Global Head Business Development

Novo Nordisk

Michelle McMurry-Heath

President and CEO

Biotechnology Innovation Organization (BIO)

Juliet Moritz

COO

Illingworth Research

Christopher Mortko

Associate VP

Merck & Co Inc.

Bibhash Mukhopadhyay

Principal

New Enterprise Associates (NEA)

Marian T. Nakada

VP Venture Investments

Johnson & Johnson Innovation, JJDC

Art Pappas

Managing Partner

Pappas Capital

Bakul Patel

Director of Digital Health Center of Excellence

Food and Drug Administration

Joseph Payne

President and CEO

Arcturus Therapeutics (NASDAQ: ARCT)

Logan Plaster

Editor-in-Chief

StartUp Health

Scott Platshon

Principal

EcoR1 Capital

Dennis J. Purcell

Founder and Senior Advisor

Aisling Capital

Yasmeen Rahimi

Senior Research Analyst

Piper Sandler

Bryan Roberts

Partner

Venrock

Scot Roberts

CSO

Altimmune (NASDAQ: ALT)

Liz Rockett

Director, Venture Capital

Kaiser Permanente Ventures

Renee Ryan

CEO

Cala Health

Una S. Ryan

Managing Director

Golden Seeds

Camille Samuels

Partner

Venrock

Tracy Saxton

Managing Director

Dolby Family Ventures

Danielle Schlosser

Head and Behavioral Health Lead

Verily Life Sciences, an Alphabet Company

Joanna Schulman

CEO

AIDIA Collective

Jodi Scott

Partner

Hogan Lovells US LLP

Tom Shebab

Managing Partner

Arboretum Ventures

Greg Simon

Consultant

Simonovation LLC

Ajit Singh

Partner

Artiman Ventures

Moncef Slaoui

Scientific Head

Operation Warp Speed

Laura Stoppel

Analyst

RA Capital Management

Christian Tucat

President, Syneos One and Real World Evidence

Syneos Health

Robert H. Underwood

Partner

Hogan Lovells

Laura Veroneau

Partner

Optum Ventures

Dhruv Vig

VP

Silicon Valley Bank

Chris Wasden

Head of HappifyDTx

Happify Health

Jingwu Zang

Founder and Honorary Chairman

I-Mab Biopharma (NASDAQ: IMAB)